SARS-CoV-2 Reinfection Risk Drops With Presence of Antibodies
TUESDAY, Dec. 29, 2020 -- Health care workers with anti-spike or anti-nucleocapsid immunoglobulin G (IgG) antibodies have a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in the following six months, according to a study published online Dec. 23 in the New England Journal of Medicine.
Sheila F. Lumley, B.M., B.Ch., from Oxford University Hospitals NHS Foundation Trust in the United Kingdom, and colleagues examined the incidence of SARS-CoV-2 infection in seropositive and seronegative health care workers attending testing of staff at Oxford University Hospitals. A total of 12,541 health care workers participated and were followed for 31 weeks after anti-spike and anti-nucleocapsid IgG measurements.
The researchers found that 11,364 health care workers had negative antibody results and 1,265 had positive antibody results, including 88 with seroconversion during follow-up. Overall, 223 anti-spike-seronegative health care workers had a positive polymerase chain reaction (PCR) test: 100 and 123 during screening while they were asymptomatic and symptomatic, respectively. Two anti-spike-seropositive health care workers had a positive PCR test, both of whom were asymptomatic when tested (1.09 and 0.13 per 10,000 days at risk, respectively; adjusted incidence rate ratio, 0.11). None of the workers with anti-spike antibodies had symptomatic infections. The results were similar when baseline status was determined using anti-nucleocapsid IgG assay alone or in combination with anti-spike IgG assay.
"The presence of anti-spike antibodies was associated with a substantially reduced risk of PCR-confirmed SARS-CoV-2 infection over 31 weeks of follow-up," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Further Support and Information on COVID-19
Read this next
MONDAY, Jan. 25, 2021 -- Patients with vitamin D deficiency are significantly more likely to be positive for COVID-19, according to a study published in the April issue of...
MONDAY, Jan. 25, 2021 -- Evidence suggests that full-dose anticoagulation treatment reduces the need for vital organ support such as ventilation and may reduce mortality in...
MONDAY, Jan. 25, 2021 -- Children and adolescents are less susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but are more infectious than...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.